secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oric Pharmaceuticals, Inc. (ORIC)
CIK:        0001796280
Form:       8-K
Filed at:   2021-08-18T23:59:59+00:00
Accession:  0001193125-21-249636
Event type: regulatory
Sentiment:  positive
Materiality: 0.40
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

SEC ends probe of ORIC CFO Piscitelli with no enforcement action
----------------------------------------------------------------

- CFO Dominic Piscitelli received SEC subpoena in March 2020 re: trading in unrelated companies.
- On August 17, 2021, SEC informed Piscitelli investigation concluded without recommending action.
- Investigation pertained solely to personal trading of other companies, not ORIC.
- Resolution removes potential overhang for CFO and company.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1796280/000119312521249636/0001193125-21-249636-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1796280/000119312521249636/d199524d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-249636

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer